Home › Polycythemia Vera › Maryland
Polycythemia Vera clinical trials in Maryland
3 studies for Polycythemia Vera are looking for participants at sites in Maryland.
INTREPID: A Study of Sapablursen Evaluating the Safety and Efficacy in Participants With Polycythemia Vera (PV)
- The Center for Cancer & Blood Disorders, Bethesda
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT07429266Study of INCA036978 in Participants With Myeloproliferative Neoplasms
- John Hopkins Hospital, Baltimore
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jul 22, 2026 · NCT07441694Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia Vera
- American Oncology Partners of Maryland, PA, Bethesda
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Mar 25, 2026 · NCT06093672From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.